Nivolumab + relatlimab for the treatment of unresectable or metastatic melanoma

被引：0
|
作者：
Kosela-Paterczyk, Hanna [1 ]
Rutkowski, Piotr [1 ]
机构：
[1] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Soft Tissue Bone Sarcoma & Melanoma, Warsaw, Poland
来源：
EXPERT OPINION ON BIOLOGICAL THERAPY | 2024年 / 24卷 / 09期
关键词：
D O I：
10.1080/14712598.2024.2390778
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：993 / 993
页数：1
相关论文
共 50 条
  • [1] Nivolumab plus relatlimab for the treatment of unresectable or metastatic melanoma
    Kosela-Paterczyk, Hanna
    Rutkowski, Piotr
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (05) : 383 - 388
  • [2] Relatlimab plus nivolumab beneficial for previously untreated metastatic or unresectable melanoma
    O'Rourke, Kate
    CANCER, 2022, 128 (10) : 1887 - 1887
  • [3] Relatlimab and nivolumab in the treatment of melanoma
    Au, Lewis
    Larkin, James
    Turajlic, Samra
    CELL, 2022, 185 (26) : 4866 - 4869
  • [4] Nivolumab and relatlimab for the treatment of melanoma
    Chen, Xuan-Yu
    Li, Yi-Dong
    Xie, Yuhao
    Cao, Lu-Qi
    Ashby, Charles R., Jr.
    Zhao, Hongbing
    Chen, Zhe-Sheng
    DRUGS OF TODAY, 2023, 59 (02) : 91 - 104
  • [5] Nivolumab/Relatlimab: A Novel Addition to Immune Checkpoint Inhibitor Therapy in Unresectable or Metastatic Melanoma
    Phillips, Allison L.
    Reeves, David J.
    ANNALS OF PHARMACOTHERAPY, 2023, 57 (06) : 738 - 745
  • [6] Complete Remission of Metastatic Melanoma of the Scalp Following Treatment With Nivolumab Plus Relatlimab
    McMinn, Mary E.
    Brister, Kelly A.
    Orr, W. Shannon
    Sheehan, Natale T.
    Christopher, Wade O.
    AMERICAN SURGEON, 2024, 90 (08) : 2078 - 2079
  • [7] TEMPORAL TRENDS IN ADVERSE EVENT COSTS WITH NIVOLUMAB plus RELATLIMAB COMBINATION THERAPY OR NIVOLUMAB MONOTHERAPY FOR PATIENTS WITH UNRESECTABLE OR METASTATIC MELANOMA
    Garcia-Horton, V
    Zhou, Z. Y.
    Moshyk, A.
    Rosenblatt, L. C.
    Patel, D.
    Xin, Y.
    Wang, Q.
    Christensen, D.
    Palaia, J.
    VALUE IN HEALTH, 2023, 26 (06) : S108 - S108
  • [8] Nivolumab/Relatlimab-rmbw: A Novel Dual Combination Therapy to Treat Adult and Pediatric Patients With Unresectable or Metastatic Melanoma
    Thomas, Baily
    Burns, Madison
    Pervanas, Helen
    Ciurescu, Daniel
    Dima, Lorena
    AMERICAN JOURNAL OF THERAPEUTICS, 2023, 30 (06) : E526 - E534
  • [9] The role of diabetes in metastatic melanoma patients treated with nivolumab plus relatlimab
    Mallardo, Domenico
    Woodford, Rachel
    Menzies, Alexander M.
    Zimmer, Lisa
    Williamson, Andrew
    Ramelyte, Egle
    Dimitriou, Florentia
    Wicky, Alexandre
    Wallace, Roslyn
    Mallardo, Mario
    Cortellini, Alessio
    Budillon, Alfredo
    Atkinson, Victoria
    Sandhu, Shahneen
    Olivier, Michielin
    Dummer, Reinhard
    Lorigan, Paul
    Schadendorf, Dirk
    Long, Georgina V.
    Simeone, Ester
    Ascierto, Paolo A.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [10] The efficacy of nivolumab for unresectable metastatic mucosal melanoma
    Takahashi, A.
    Tsutsumida, A.
    Namikawa, K.
    Nakamura, Y.
    Muto, I.
    Yamazaki, N.
    ANNALS OF ONCOLOGY, 2016, 27
12345